Yuemin Wang

Dr. Yuemin Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
XMXiaodan Ma
Xiaodan Ma
XCXiaoqing Chi
Xiaoqing Chi
LYLijia Yuan
Lijia Yuan
YWYuemin Wang
Yuemin Wang
ZLZoushuyi Li
Zoushuyi Li
SHSonghua Hu
Songhua Hu

Verified
Journal Article
Open access
PDF file
ZYZetao Yu
Zetao Yu
JWJing Wang
Jing Wang
WXWenqiang Xia
Wenqiang Xia
YWYuemin Wang
Yuemin Wang
YZYafen Zhang
Yafen Zhang
ZYZihong Ye
Zihong Ye
Inflammatory responses and tumor developments are closely related, with interleukin-6 (IL-6) playing important roles in both processes. IL-6 has been extensively identified as a potential tumor biomarker. This study developed an isotope dilution mass spectrometry (IDMS) method for quantifying IL-6 based on signature peptides. These peptides were screened by excluding those with missed cleavage or post-translational modification. The method’s accuracy was verified using amino acid-based IDMS, in which purified IL-6 protein samples were quantified after hydrolyzing them into amino acids, and no significant difference was observed (p-value < 0.05). The method demonstrated good linearity and sensitivity upon testing. The specificity and matrix effect of the method were verified, and a precision study showed that the coefficient of variation was less than 5% for both the intra-day and inter-day tests. Compared to immunoassays, this method offers distinct advantages, such as the facilitation of multi-target analysis. Furthermore, the peptides used in this study are much more convenient for storage and operation than the antibodies or purified proteins typically used in immunoassays.

6 February 2026 in Frontiers in Chemistry
Verified
Journal Article
Open access
CBChenchen Bao
Chenchen Bao
JWJing Wang
Jing Wang
WXWenqiang Xia
Wenqiang Xia
KYKe Yang
Ke Yang
XSXinchang Shi
Xinchang Shi
YZYafen Zhang
Yafen Zhang
Tumor necrosis factor-α (TNF-α) is an important inflammatory mediator and has been widely recognized as a diagnostic biomarker for various autoimmune and infectious diseases in clinical practice, such as rheumatoid arthritis. In this study, we established an SI-traceable reference method to quantify TNF-α based on liquid chromatography–isotope dilution tandem mass spectrometry (LC-IDMS) with amino acid or peptide analysis. The assays exhibited good linearity ( R 2 > 0.999), repeatability (RSD < 3%) and accuracy, which had been verified using certified reference materials (CRMs). Stable isotope-labeled version of three amino acids (valine, phenylalanine, and leucine) and two peptides were used as an internal standard to minimize assay variability. For amino acid analysis, TNF-α could be fully hydrolyzed into amino acids after 60 h at 110 °C. The result based on the amino acid analysis was (0.770 ± 0.033) mg/g, expressed as a mass fraction (mg TNF-α per g of total solution), with an expanded uncertainty ( k = 2). For peptide analysis, ANALLANGVELR (AR-12) and VVNLLSAIK (VK-9) were chosen as specific peptides. After 36 h of tryptic proteolysis, TNF-α could be completely proteolyzed into AR-12 and VK-9. Based on characteristic peptide analysis, the result was 0.769 ± 0.046 mg/g ( k = 2 ). There was no significant difference between these two analyses, and the concentration of TNF-α was 0.770 ± 0.057 mg/g ( k = 2 ), which was traceable to the International System of Units. Both methods developed in this study can accurately determine the concentration of TNF-α and are useful for detection kit development and instrument calibration. In addition, application data for reagents certified by these methods in cell apoptosis assays and kit evaluation are provided: TNF-α-induced cell apoptosis was significantly attenuated by antagonists, while detection kits based on three different principles exhibited good repeatability (RSD < 9%) and linearity ( R 2 > 0.999). This accurate, SI-traceable method can improve clinical TNF-α assay standardization and biomarker reliability.